These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16887387)

  • 1. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
    Coletta AP; Tin L; Loh PH; Clark AL; Cleland JG
    Eur J Heart Fail; 2006 Aug; 8(5):547-9. PubMed ID: 16887387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.
    Coletta AP; Cullington D; Clark AL; Cleland JG
    Eur J Heart Fail; 2008 Dec; 10(12):1264-7. PubMed ID: 19008149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA.
    Cleland JG; Coletta AP; Clark AL; Velavan P; Ingle L
    Eur J Heart Fail; 2005 Aug; 7(5):937-9. PubMed ID: 16048744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.
    Cleland JG; Coletta AP; Nikitin NP; Clark AL
    Eur J Heart Fail; 2006 May; 8(3):326-9. PubMed ID: 16698503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update.
    Cleland JG; Coletta AP; Cullington D; Castiello T; de Boer RA; Clark AL
    Eur J Heart Fail; 2011 Dec; 13(12):1376-80. PubMed ID: 22102626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
    Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
    Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.
    Cleland JG; Coletta AP; Torabi A; Clark AL
    Eur J Heart Fail; 2009 Aug; 11(8):802-5. PubMed ID: 19633104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF.
    Cleland JG; Coletta AP; Castiello T; Clark AL
    Eur J Heart Fail; 2011 Oct; 13(10):1147-51. PubMed ID: 21896537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.
    Cleland JG; Abdellah AT; Khaleva O; Coletta AP; Clark AL
    Eur J Heart Fail; 2007 Oct; 9(10):1070-3. PubMed ID: 17890152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
    J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
    van Veldhuisen DJ; Dickstein K; Cohen-Solal A; Lok DJ; Wasserman SM; Baker N; Rosser D; Cleland JG; Ponikowski P
    Eur Heart J; 2007 Sep; 28(18):2208-16. PubMed ID: 17681958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF.
    Cleland JG; Coletta AP; Abdellah AT; Witte KK; Hobson N; Clark AL
    Eur J Heart Fail; 2007 Aug; 9(8):850-3. PubMed ID: 17644412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure.
    Pellicori P; Clark AL
    Eur J Heart Fail; 2015 Sep; 17(9):979-83. PubMed ID: 26289928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.
    Cleland JG; Coletta AP; Clark AL
    Eur J Heart Fail; 2007; 9(6-7):740-5. PubMed ID: 17481946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE.
    Cleland JG; Coletta AP; Lammiman M; Witte KK; Loh H; Nasir M; Clark AL
    Eur J Heart Fail; 2005 Oct; 7(6):1070-5. PubMed ID: 16227146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
    McMurray JJ; Anand IS; Diaz R; Maggioni AP; O'Connor C; Pfeffer MA; Polu KR; Solomon SD; Sun Y; Swedberg K; Tendera M; van Veldhuisen DJ; Wasserman SM; Young JB;
    Eur J Heart Fail; 2009 Aug; 11(8):795-801. PubMed ID: 19633103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II.
    Cleland JG; Coletta AP; Freemantle N; Clark AL
    Eur J Heart Fail; 2011 Jul; 13(7):805-8. PubMed ID: 21712293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.